BACKGROUND: The autoantibodies (AAs) against angiotensin AT(1) receptors (AT(1) -AAs) have been discovered in patients with preeclampsia, malignant hypertension, and essential hypertension (EH); however, the mechanism of AA production remains to be investigated. HYPOTHESIS: Polymorphisms of HLA-DRB1 or HLA-DQB1 are related to production of AAs in autoimmune diseases. We hypothesis that the polymorphisms of the HLA molecules are also associated with production of AT(1) -AAs in patients with EH. METHODS: We enrolled 394 patients with EH and 224 normotensive subjects in this study. Autoantibodies in sera of donors were detected by enzyme-linked immunosorbent assay. The subjects' clinical data were collected, including gender, age, body mass index, blood pressure, smoking status, and diabetes. The patients and the normotensive subjects were classified respectively into AA-positive and AA-negative groups. Typing of DNA for HLA-DRB1 and HLA-DQB1 alleles was done by polymerase chain reaction amplification with sequence-specific primers. RESULTS: Thirteen HLA-DRB1 and 7 HLA-DQB1 alleles were found in this population. The frequencies of AT(1) -AAs were related to blood pressure level. The frequency of AT(1) -AAs in the EH group was higher than that in the normotensive group (P = 0.0001). The levels of AAs in different groups of EH show a significant difference (P = 0.027). In addition, HLA-DRB1(*) 04 and HLA-DRB1(*) 14 (odds ratio [OR]: 3.06, 95% confidence interval [CI]: 1.56-5.97, P = 0.001; and OR: 2.53, 95% CI: 1.080-5.91, P = 0.033, respectively) were related to AT(1) -AA production in normotensive subjects after adjusting for covariants. The HLA-DRB1(*) 04 allele might be related to AT(1) -AA production in hypertensive subjects, and the P value was of baseline statistical significance after adjusting for blood pressure and other covariants (OR: 1.63, 95% CI: 0.95-2.78, P = 0.070). CONCLUSIONS: These results suggest a difference in the immunogenetic background between the positive and negative AAs with hypertension or normotension. The HLA-DRB1(*) 04 allele increases the risk for AT(1) -AA production. 2011 Wiley Periodicals, Inc.
BACKGROUND: The autoantibodies (AAs) against angiotensin AT(1) receptors (AT(1) -AAs) have been discovered in patients with preeclampsia, malignant hypertension, and essential hypertension (EH); however, the mechanism of AA production remains to be investigated. HYPOTHESIS: Polymorphisms of HLA-DRB1 or HLA-DQB1 are related to production of AAs in autoimmune diseases. We hypothesis that the polymorphisms of the HLA molecules are also associated with production of AT(1) -AAs in patients with EH. METHODS: We enrolled 394 patients with EH and 224 normotensive subjects in this study. Autoantibodies in sera of donors were detected by enzyme-linked immunosorbent assay. The subjects' clinical data were collected, including gender, age, body mass index, blood pressure, smoking status, and diabetes. The patients and the normotensive subjects were classified respectively into AA-positive and AA-negative groups. Typing of DNA for HLA-DRB1 and HLA-DQB1 alleles was done by polymerase chain reaction amplification with sequence-specific primers. RESULTS: Thirteen HLA-DRB1 and 7 HLA-DQB1 alleles were found in this population. The frequencies of AT(1) -AAs were related to blood pressure level. The frequency of AT(1) -AAs in the EH group was higher than that in the normotensive group (P = 0.0001). The levels of AAs in different groups of EH show a significant difference (P = 0.027). In addition, HLA-DRB1(*) 04 and HLA-DRB1(*) 14 (odds ratio [OR]: 3.06, 95% confidence interval [CI]: 1.56-5.97, P = 0.001; and OR: 2.53, 95% CI: 1.080-5.91, P = 0.033, respectively) were related to AT(1) -AA production in normotensive subjects after adjusting for covariants. The HLA-DRB1(*) 04 allele might be related to AT(1) -AA production in hypertensive subjects, and the P value was of baseline statistical significance after adjusting for blood pressure and other covariants (OR: 1.63, 95% CI: 0.95-2.78, P = 0.070). CONCLUSIONS: These results suggest a difference in the immunogenetic background between the positive and negative AAs with hypertension or normotension. The HLA-DRB1(*) 04 allele increases the risk for AT(1) -AA production. 2011 Wiley Periodicals, Inc.
Authors: Vinicius Tragante; Michael R Barnes; Santhi K Ganesh; Matthew B Lanktree; Wei Guo; Nora Franceschini; Erin N Smith; Toby Johnson; Michael V Holmes; Sandosh Padmanabhan; Konrad J Karczewski; Berta Almoguera; John Barnard; Jens Baumert; Yen-Pei Christy Chang; Clara C Elbers; Martin Farrall; Mary E Fischer; Tom R Gaunt; Johannes M I H Gho; Christian Gieger; Anuj Goel; Yan Gong; Aaron Isaacs; Marcus E Kleber; Irene Mateo Leach; Caitrin W McDonough; Matthijs F L Meijs; Olle Melander; Christopher P Nelson; Ilja M Nolte; Nathan Pankratz; Tom S Price; Jonathan Shaffer; Sonia Shah; Maciej Tomaszewski; Peter J van der Most; Erik P A Van Iperen; Judith M Vonk; Kate Witkowska; Caroline O L Wong; Li Zhang; Amber L Beitelshees; Gerald S Berenson; Deepak L Bhatt; Morris Brown; Amber Burt; Rhonda M Cooper-DeHoff; John M Connell; Karen J Cruickshanks; Sean P Curtis; George Davey-Smith; Christian Delles; Ron T Gansevoort; Xiuqing Guo; Shen Haiqing; Claire E Hastie; Marten H Hofker; G Kees Hovingh; Daniel S Kim; Susan A Kirkland; Barbara E Klein; Ronald Klein; Yun R Li; Steffi Maiwald; Christopher Newton-Cheh; Eoin T O'Brien; N Charlotte Onland-Moret; Walter Palmas; Afshin Parsa; Brenda W Penninx; Mary Pettinger; Ramachandran S Vasan; Jane E Ranchalis; Paul M Ridker; Lynda M Rose; Peter Sever; Daichi Shimbo; Laura Steele; Ronald P Stolk; Barbara Thorand; Mieke D Trip; Cornelia M van Duijn; W Monique Verschuren; Cisca Wijmenga; Sharon Wyatt; J Hunter Young; Aeilko H Zwinderman; Connie R Bezzina; Eric Boerwinkle; Juan P Casas; Mark J Caulfield; Aravinda Chakravarti; Daniel I Chasman; Karina W Davidson; Pieter A Doevendans; Anna F Dominiczak; Garret A FitzGerald; John G Gums; Myriam Fornage; Hakon Hakonarson; Indrani Halder; Hans L Hillege; Thomas Illig; Gail P Jarvik; Julie A Johnson; John J P Kastelein; Wolfgang Koenig; Meena Kumari; Winfried März; Sarah S Murray; Jeffery R O'Connell; Albertine J Oldehinkel; James S Pankow; Daniel J Rader; Susan Redline; Muredach P Reilly; Eric E Schadt; Kandice Kottke-Marchant; Harold Snieder; Michael Snyder; Alice V Stanton; Martin D Tobin; André G Uitterlinden; Pim van der Harst; Yvonne T van der Schouw; Nilesh J Samani; Hugh Watkins; Andrew D Johnson; Alex P Reiner; Xiaofeng Zhu; Paul I W de Bakker; Daniel Levy; Folkert W Asselbergs; Patricia B Munroe; Brendan J Keating Journal: Am J Hum Genet Date: 2014-02-20 Impact factor: 11.025
Authors: Christopher T Chan; Maggie Lieu; Ban-Hock Toh; Tin S Kyaw; Alexander Bobik; Christopher G Sobey; Grant R Drummond Journal: Biomed Res Int Date: 2014-06-23 Impact factor: 3.411
Authors: Renna Luo; Chen Liu; Serra E Elliott; Wei Wang; Nicholas Parchim; Takayuki Iriyama; Patrick S Daugherty; Lijian Tao; Holger K Eltzschig; Sean C Blackwell; Baha M Sibai; Rodney E Kellems; Yang Xia Journal: J Am Heart Assoc Date: 2016-06-30 Impact factor: 5.501
Authors: Vivian K Kawai; Mingjian Shi; Qiping Feng; Cecilia P Chung; Ge Liu; Nancy J Cox; Gail P Jarvik; Ming T M Lee; Scott J Hebbring; John B Harley; Kenneth M Kaufman; Bahram Namjou; Eric Larson; Adam S Gordon; Dan M Roden; C Michael Stein; Jonathan D Mosley Journal: Arthritis Rheumatol Date: 2020-08-06 Impact factor: 15.483